For oral delivery, we engineer formulations that overcome solubility, stability, and bioavailability challenges while ensuring patient compliance. Key capabilities include: • Enhanced bioavailability through nanoparticle engineering and solubility improvement • No fed/fasted variability, improving pharmacokinetic predictability • Taste-masking strategies for improved patient acceptance • Enhanced chemical and physical stability • Targeted, sustained, and extended-release formulations for optimized therapeutic profiles Our technologies support both conventional and nanoparticle-based oral dosage forms.
